Neonatal scopolamine or antidepressant treatment: Effect on development of hamster circadian rhythms

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 369-373

  Klemfuss, Harry ^a   Gillin, J Christian ^a  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Affective disorders; Chlorimipramine; Circadian; Depression; Imipramine; Muscarinic; Rhythms; Scopolamine

Indexed keywords

ANTIDEPRESSANT AGENT; CLOMIPRAMINE; IMIPRAMINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; OXOTREMORINE; SCOPOLAMINE;

AFFECTIVE NEUROSIS; ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL RHYTHM; CIRCADIAN RHYTHM; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; FEMALE; HAMSTER; LONG TERM CARE; MALE; MONOAMINE METABOLISM; PRIORITY JOURNAL; RUNNING;

EID: 0032006534     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00409-7     Document Type: Article

References (41)

1. Ahlbom J., Fredricksson A., Eriksson P. Exposure to an organophosphate (DFP) during a defined period in neonatal life induces permanent changes in brain muscarinic receptors and behaviour in adult mice. Brain Res. 677:1995;13-19.
2. Baldessarini R. J. Drugs and the treatment of psychiatric disorders. Gilman A. G., Goodman L. S., Rall T., Murad F. The pharmacological basis of therapeutics. 1985;416-417 Macmillan, New York.
3. Benfield D. P., Harries C. M., Luscombe D. K. Some pharmacological aspects of desmethylclomipramine. Postgrad. Med. J. (Suppl.). 56:1996;13-18.
4. Chao H. M., McEwen B. S. Glucocorticoid regulation of neuropeptide mRNAs in the rat striatum. Brain Res. Mol. Brain Res. 9:1991;307-311.
5. Coppen A., Prange A. J., Whybrow P. C., Noguera R. Abnormalities of indoleamines in affective disorders. Arch. Gen. Psychiatry. 26:1972;474-478.
6. Gillin J. C., Lauriello J., Kelsoe J. R., Rapaport M., Golshan S., Kenny W. M., Sutton L. No antidepressant effect of biperiden compared with placebo in depression. A double-blind 6-week clinical trial Psychiatr. Res. 58:1995;99-105.
7. Gillin J. C., Sutton L., Ruiz C., Darko D., Golshan S., Risch S. C., Janowsky D. The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group. Biol. Psychiatry. 30:1991;157-169.
8. Hilakivi L. A., Hilakivi I. Increased adult behavioral 'despair' in rats neonatally exposed to desipramine or zimeldine. An animal model of depression? Pharmacol. Biochem. Behav. 28:1987;367-369.
9. Hilakivi L. A., Taira T., Hilakivi I., Loikas P. Neonatal treatment with monoamine uptake inhibitors alters later response in behavioural 'despair' test to beta and GABA-B receptor agonists. Pharmacol. Toxicol. 63:1988;57-61.
10. Janowsky D. S., El-Yousef M. K., Davis J. M. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. 2:1972;632-635.
11. Klemfuss H., Clopton P. Seeking tau. a comparison of six methods J. Interdiscipl. Cycle Res. 24:1993;1-16.
12. Klemfuss, H.; Clopton, P.: The RATMAN programs for biological rhythm analysis. http://varesearch. ucsd. edu/klemfuss/ratman. htm 1995.
13. Klemfuss H., Ramos P. R., Gillin J. C. Amplitude of wheelrunning rhythms is decreased in hamsters treated with scopolamine as neonates. Soc. Neurosci. Abstr. 21:1995.
14. Kripke D. F., Mullaney D. J., Gabriel S. The chronopharmacology of antidepressant drugs. Reinberg A., Smolensky M., Labrecque G. Annual review of chronopharmacology, vol. 2. 1985;275-289 Pergamon Press, Oxford.
15. Liu C., Gillette M. U. Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night. J. Neurosci. 16:1996;744-751.
16. Mirmiran M., van de Poll N. E., Corner M. A., van Oyen H. G., Bour H. L. Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development. Effects upon adult sleep and behavior in the rat Brain Res. 204:1981;129-146.
17. Nelson W., Tong Y. L., Lee J.-K., Halberg F. Methods for cosinor-rhythmometry. Chronobiologia. 6:1979;305-323.
18. Overstreet D. H., Janowsky D. S. A cholinergic supersensitivity model of depression. Boulton A., Baker G., Martin-Iverson M. Neuromethods, vol. 19: 1991;81-113 Humana Press, Animal models in psychiatry, II. New York.
19. Prathiba J., Kumar K. B., Karanth K. S. Effects of neonatal clomipramine on cholinergic receptor sensitivity and passive avoidance behavior in adult rats. J. Neural Transm. 100:1995;93-99.
20. Price L. H., Charney D. S., Delgado P. L., Goodman W. K., Krystal J. H., Woods S. W., Heninger G. R. Clinical data on the role of serotonin in the mechanism(s) of action of antidepressant drugs. J. Clin. Psychiatry. 51:1990;44-50.
21. Raoux N., Benoit O., Dantchev N., Denise P., Franc B., Allilaire J. F., Widlocher D. Circadian pattern of motor activity in major depressed patients undergoing antidepressant therapy. relationship between actigraphic measures and clinical course Psychiatr. Res. 52:1994;85-98.
22. Rosenthal M. S., Vogel G. W. The effect of a 3-day increase of ambient temperature toward the thermoneutral zone on rapid eye movement sleep in the rat. Sleep. 16:1993;702-705.
23. Rosenwasser A. M., Hayes M. J. Neonatal desipramine treatment alters free-running circadian drinking rhythms in rats. Psychopharmacology (Berlin). 115:1994;237-244.
24. Schulz H., Lund R. On the origin of early REM episodes in the sleep of depressed patients. A comparison of three hypotheses Psychiatr. Res. 16:1985;65-77.
25. Shiromani P. J., Klemfuss H., Lucero S., Overstreet D. H. Diurnal rhythm of core body temperature is phase advanced in a rodent model of depression. Biol. Psychiatry. 29:1991;923-930.
26. Shiromani P. J., Overstreet D. Free-running period of circadian rhythms is shorter in rats with a genetically upregulated central cholinergic system. Biol. Psychiatry. 36:1994;622-626.
27. Shiromani P. J., Velazquez-Moctezuma J., Overstreet D., Shalauta M., Lucero S., Floyd C. Effects of sleep deprivation on sleepiness and increased REM sleep in rats selectively bred for cholinergic hyperactivity. Sleep. 14:1991;116-120.
28. Souetre E., Salvati E., Belugou J. L., Pringuey D., Candito M., Krebs B., Ardisson J. L., Darcourt G. Circadian rhythms in depression and recovery. Evidence for blunted amplitude as the main chronobiological abnormality Psychiatr. Res. 28:1989;263.
29. Sutin E. L., Shiromani P. J., Kelsoe J. R., Storch F. I., Gillin J. C. Rapid-eye movement sleep and muscarinic receptor binding in rats are augmented during withdrawal from chronic scopolamine treatment. Life Sci. 39:1986;2419-2427.
30. Trachsel L., Heller H. C., Miller J. D. Nicotine phase-advances the circadian neuronal activity rhythm in rat suprachiasmatic nuclei explants. Neuroscience. 65:1995;797-803.
31. Velazquez-Moctezuma J., Aguilar-Garcia A., Diaz-Ruiz O. Behavioral effects of neonatal treatment with clomipramine, scopolamine, and idazoxan in male rats. Pharmacol. Biochem. Behav. 46:1993;215-217.
32. Velazquez-Moctezuma J., Diaz Ruiz O. Neonatal treatment with clomipramine increased immobility in the forced swim test. An attribute of animal models of depression Pharmacol. Biochem. Behav. 42:1992;737-739.
33. Velazquez Moctezuma J., Shalauta M. D., Gillin J. C., Shiromani P. J. Differential effects of cholinergic antagonists on REM sleep components. Psychopharmacol. Bull. 26:1990;349-353.
34. Vogel G., Hagler M. Effects of neonatally administered iprindole on adult behaviors in rats. Pharmacol. Biochem. Behav. 55:1996;157-161.
35. Vogel G., Hagler M., Hennessey A., Richard C. Dose-dependent decrements in adult male rat sexual behavior after neonatal clorimipramine treatment. Pharmacol. Biochem. Behav. 54:1996;605-609.
36. Vogel G., Neill D., Hagler M., Kors D. A new animal model of endogenous depression. A summary of present findings Neurosci. Biobehav. Rev. 14:1990;85-91.
37. Vogel G., Neill D., Hagler M., Kors D., Hartley P. Decreased intracranial self-stimulation in a new animal model of endogenous depression. Neurosci. Biobehav. Rev. 14:1990;65-68.
38. Vogel G. W., Buffenstein A., Minter K., Hennessey A. Drug effects on REM sleep and on endogenous depression. Neurosci. Biobehav. Rev. 14:1990;49-63.
39. Wehr T. A., Wirz-Justice A., Goodwin F. K., Duncan W. C., Gilin J. C. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science. 206:1979;710-713.
40. Yavari P., Vogel G. W., Neill D. B. Decreased raphe unit activity in a rat model of endogenous depression. Brain Res. 611:1993;31-36.
41. Zhang Y., Zee P. C., Kirby J. D., Takahashi J. S., Turek F. W. A cholinergic antagonist, mecamylamine, blocks light-induced fos immunoreactivity in specific regions of the hamster suprachiasmatic nucleus. Brain Res. 615:1993;107-112.